Healthcare / Medical Care FacilitiesSES
$0.03
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 23%
FCF escenarios
weak_data · normalized FCF $-13.5M · quality 67.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
13/100
F
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$43M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-47.0%
↓Gross Margin
91.8%
↑Debt/Equity
1.05
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+4.4%
FCF CAGR
—
FCF margin
-68.6%
FCF / Net income
0.41x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $15.7M · net income $-26.2M · FCF $-10.8M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $15.7M | $15.7M | $16.6M | $16.2M | $13.8M |
| Net Income | $-26.2M | $-26.2M | $-37.4M | $-18.1M | $-12.4M |
| EBITDA | $-11.1M | $-11.1M | $-13.4M | $-10.8M | $-8.0M |
| EPS | -0.03 | -0.03 | -0.05 | -0.02 | -0.01 |
| Gross Margin | 91.8% | 91.8% | 92.3% | 92.3% | 91.2% |
| Operating Margin | -142.3% | -142.3% | -125.6% | -84.6% | -96.4% |
| Net Margin | -166.5% | -166.5% | -224.9% | -111.3% | -90.0% |
| Balance Sheet | |||||
| Debt/Equity | 1.05 | 1.05 | 0.56 | 1.80 | 1.62 |
| Current Ratio | 0.15 | 0.15 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-10.8M | $-10.8M | $-13.5M | $-17.7M | $-9.9M |
| Returns | |||||
| ROE | -47.0% | -47.0% | -45.8% | -40.2% | -23.0% |
| Valuation | |||||
| P/B | 0.62 | 0.62 | 1.01 | — | — |
| Growth & Yield | |||||
| Revenue Growth | -5.6% | -5.6% | 2.5% | 17.6% | — |
| EPS Growth | 43.5% | 43.5% | -153.8% | -45.4% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+23.3%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.05 → -0.03
Residual
+23.3%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.